Status:
COMPLETED
Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
Dutch Cancer Society
Conditions:
Non-seminomatous Testicular Cancer
Eligibility:
MALE
Brief Summary
BACKGROUND: Evidence has emerged that patients cured with cisplatin-bleomycin chemotherapy from disseminated testicular cancer (TC) develop a large number of cardiovascular risk factors (CRF) several...
Eligibility Criteria
Inclusion
- Patients with non-seminomatous testicular cancer
- Have been uniformly treated with orchidectomy and cisplatin-bleomycin combination chemotherapy at the University Hospital Groningen, The Netherlands, since 1977 but before 01-01-2000 are eligible.
Exclusion
- N/A
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT00161174
Start Date
July 1 2005
End Date
January 1 2011
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Groningen
Groningen, Netherlands, 9713 GZ